Business
ChromaDex to Participate at the 35th Annual ROTH Capital Partners Conference on March 13, 2023
LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced that
About this update from Niagen Bioscience, Inc.
[{"type":"text","content":" LOS ANGELES--(BUSINESS WIRE)--\nChromaDex Corp. (NASDAQ:CDXC) (“the Company”) a global bioscience company dedicated to healthy aging, today announced that senior management will participate at the 35th annual ROTH Capital Partners Conference at the Ritz-Carlton in Dana Point, CA. The Annual ROTH Conference is one of the largest in the nation for small-cap companies and combines company presentations, Q&A sessions and management 1-on-1 meetings. The award-winning ROTH Research Team identified ChromaDex as one of the distinguished presenting companies within the healthcare sector.\n\nRob Fried, ChromaDex’s CEO, is scheduled to present in an in-person fireside chat on Monday, March 13th, at 11:00 a.m. Pacific Time. ChromaDex management will also attend one-on-one meetings with institutional investors throughout the day.\n\nFor more information about the conference or to schedule a one-on-one meeting with ChromaDex management, please contact your ROTH representative.\n\nFor additional information on ChromaDex, visit www.chromadex.com.\n\nAbout ChromaDex:\n\nChromaDex Corp. is a global bioscience company dedicated to healthy aging. The ChromaDex team, which includes world-renowned scientists, is pioneering research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. ChromaDex is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen®. Nicotinamide riboside and other NAD+ precursors are protected by ChromaDex’s patent portfolio. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.\n\nForward-Looking Statements:\n\nThis release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities and Exchange Act of 1934, as amended. Statements that are not a description of historical facts constitute forward-looking statements and may often, but not always, be identified by the use of such words as \"expects,\" \"anticipates,\" \"intends,\" \"estimates,\" \"plans,\" \"potential,\" \"possible,\" \"probable,\" \"believes,\" \"seeks,\" \"may,\" \"will,\" \"should,\" \"could\" or the negative of such terms or other similar expressions. Risks that contr...